Summary of opinion: Fasenra, 19/09/2024 Positive
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Summary of opinion: Fasenra, 19/09/2024 Positive
Summary of opinion: Dupixent, 19/09/2024 Positive
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Summary of opinion: Dupixent, 19/09/2024 Positive
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Status: Opinion
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Status: Opinion
Summary of opinion: Zavicefta, 19/09/2024 Positive
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Summary of opinion: Zavicefta, 19/09/2024 Positive
Clinical Trial Information System (CTIS) evaluation timelines
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Clinical Trial Information System (CTIS) evaluation timelines
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal group A, B, C, W and Y vaccine, Status: Opinion
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal group A, B, C, W and Y vaccine, Status: Opinion
Summary of opinion: Darzalex, 19/09/2024 Positive
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Summary of opinion: Darzalex, 19/09/2024 Positive
Summary of opinion: Keytruda, 19/09/2024 Positive
Submitted by Anonymous (not verified) on 20 September 2024 - 12:00
Summary of opinion: Keytruda, 19/09/2024 Positive
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 9, Status: Authorised
Submitted by Anonymous (not verified) on 20 September 2024 - 11:52
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 20 September 2024 - 11:50
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 7, Status: Authorised